eDrugSearch uploadxml
eDrug Search

View drugs by alphabetical list:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

  • Home
  • Pharmacy Ratings
  • Blog
  • Community
  • Library
  • About Pharmacies
  • Tell a Friend:

You are here:Home»Prescription Drugs A to Z»Levora

Levora Price Comparison

Buy Levora Online and Read Levora Reviews

Use eDrugSearch to check Levora price comparison results below and read verified Levora reviews before you buy Levora online. Simply click the "Buy Now" button or the "Pharmacy Logo" to buy Levora online from one of our licensed Canadian pharmacies.

*To refine your Levora price comparison search further click on the "All, Brand or Generic" tab so you can view all the Levora prices located within our database.

Select Dosage

  • All dosages
  • 0.15mg/0.03mg Levora
  • Compare Prices
  • Read Reviews
  • Q & A
  • Description
  • Coupons
  • All
  • Brand
  • Generic
Online Pharmacydesc
Drug Namedesc
Quantitydesc
Total Pricedesc
Price Per Pilldesc
Check Availability

Levora Prices from Quality Prescription Drugs

Levora 0.15mg/0.03mg

84
Brand

$79.00

viewdetail

$ 0.94

Go To STORE
35.25%
When you buy 1 container of Levora 0.15mg/0.03mg for $79.00 at Quality Prescription Drugs compared to the max price for 84 of $122.00.
Quality Prescription Drugs Pharmacy is certified by
1 container (84): Levora 0.15mg/0.03mg
$79.00
Regular Shipping:
$9.00
Total:
$88
Go To Store

Levora Prices from Online Pharmacies Canada

Levora 0.15mg/0.03mg

84
Brand

$79.39

viewdetail

$ 0.95

Go To STORE
34.93%
When you buy 1 container of Levora 0.15mg/0.03mg for $79.39 at Online Pharmacies Canada compared to the max price for 84 of $122.00.
Online Pharmacies Canada Pharmacy is certified by
1 container (84): Levora 0.15mg/0.03mg
$79.39
Regular Shipping:
$9.95
Total:
$89.34
Go To Store

Levora Prices from Pharma Passport

Levora 0.15mg/0.03mg

84
Brand

$79.79

viewdetail

$ 0.95

Go To STORE
34.60%
When you buy 1 container of Levora 0.15mg/0.03mg for $79.79 at Pharma Passport compared to the max price for 84 of $122.00.
1 container (84): Levora 0.15mg/0.03mg
$79.79
Regular Shipping:
$9.95
Total:
$89.74
Go To Store

Levora Prices from Online Canadian Pharmacy

Levora 0.15mg/0.03mg

84
Brand

$120.78

viewdetail

$ 1.44

Go To STORE
1.00%
When you buy 1 container of Levora 0.15mg/0.03mg for $120.78 at Online Canadian Pharmacy compared to the max price for 84 of $122.00.
1 container (84): Levora 0.15mg/0.03mg
$120.78
Regular Shipping:
$0.00
Total:
$120.78
Go To Store

Levora Prices from MapleLeafMeds

Levora 0.15mg/0.03mg

84
Brand

$122.00

viewdetail

$ 1.45

Go To STORE
0.00%
When you buy 1 container of Levora 0.15mg/0.03mg for $122.00 at MapleLeafMeds compared to the max price for 84 of $122.00.
MapleLeafMeds Pharmacy is certified by
1 container (84): Levora 0.15mg/0.03mg
$122.00
Regular Shipping:
$9.95
Total:
$131.95
Go To Store

Levora Prices from PrescriptionPoint

Levora 0.15mg/0.03mg

84
Brand

$122.00

viewdetail

$ 1.45

Go To STORE
0.00%
When you buy 1 container of Levora 0.15mg/0.03mg for $122.00 at PrescriptionPoint compared to the max price for 84 of $122.00.
PrescriptionPoint Pharmacy is certified by
1 container (84): Levora 0.15mg/0.03mg
$122.00
Regular Shipping:
$9.95
Total:
$131.95
Go To Store

Levora Prices from DoctorSolve

Levora 0.15mg/0.03mg

84
Brand

$122.00

viewdetail

$ 1.45

Go To STORE
0.00%
When you buy 1 container of Levora 0.15mg/0.03mg for $122.00 at DoctorSolve compared to the max price for 84 of $122.00.
DoctorSolve Pharmacy is certified by
1 container (84): Levora 0.15mg/0.03mg
$122.00
Regular Shipping:
$9.95
Coupon Discount
$32.9875
Total:
$98.9625
Go To Store

Levora Information

Product Code
52544-279
Company Name
Watson Pharma Inc.
Dosage From
KIT

Levora () Supplemental Patient Material

Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.

Levora () Oral Contraceptive Agents Description

Levonorgestrel is a totally synthetic progestogen with the chemical name (–)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one. Ethinyl estradiol is an estrogen with the chemical name 19-Nor-17α-pregna-1,3,5(10)-trien-20-yne-3,17-diol. Their structural formulae follow:

The white Levora () 0.15/30 tablets contain the following inactive ingredients: croscarmellose sodium, lactose, magnesium stearate, microcrystalline cellulose, and povidone.

The inactive peach tablets in the 28-day regimen of Levora () 0.15/30 contain the following inactive ingredients: FD&C Yellow No. 6 Lake, Lactose Anhydrous, Lactose Monohydrate, Magnesium Stearate and Microcrystalline Cellulose.

Levora () Clinical Pharmacology

Combination oral contraceptives act by suppression of gonadotrophins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which may reduce the likelihood of implantation).

Levora () Indications And Usage

Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.

Levora () Contraindications

Oral contraceptives should not be used in women who have the following conditions:

Levora () Warnings

The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, hypercholesterolemia, obesity, and diabetes.

Practitioners prescribing oral contraceptives should be familiar with the following information relating to these risks.

The information contained in this package insert is principally based on studies carried out in patients who used oral contraceptives with higher formulations of both estrogens and progestogens than those in common use today. The effect of long-term use of the oral contraceptives with lower formulations of both estrogens and progestogens remains to be determined.

Throughout this labeling, epidemiological studies reported are of two types: retrospective or case control studies and prospective or cohort studies. Case control studies provide a measure of the relative risk of a disease. Relative risk, the of the incidence of a disease among oral contraceptive users to that among non-users, cannot be assessed directly from case control studies, but the odds ratio obtained is a measure of relative risk. The relative risk does not provide information on the actual clinical occurrence of a disease. Cohort studies provide not only a measure of the relative risk but a measure of attributable risk, which is the in the incidence of disease between oral contraceptive users and non-users. The attributable risk does provide information about the actual occurrence of a disease in the population. (Adapted from ref. 12 and 13 with the author’s permission.) For further information, the reader is referred to a text on epidemiological methods.

Levora () Precautions

Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.

Levora () Adverse Reactions

An increased risk of the following serious adverse reactions has been associated with the use of oral contraceptives (see section):

There is evidence of an association between the following conditions and the use of oral contraceptives, although additional confirmatory studies are needed:

The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related:

The following adverse reactions have been reported in users of oral contraceptives and the association has been neither confirmed nor refuted:

Levora () Overdosage

Serious ill effects have not been reported following acute ingestion of large doses of oral contraceptives by young children. Overdosage may cause nausea, and withdrawal bleeding may occur in females.

Levora () Non-contraceptive Health Benefits

The following non-contraceptive health benefits related to the use of oral contraceptives are supported by epidemiological studies which largely utilized oral contraceptive formulations containing estrogen doses exceeding 0.035 mg of ethinyl estradiol or 0.05 mg of mestranol.

Effects on menses:

Effects related to inhibition of ovulation:

Effects from long-term use:

Levora () Dosage And Administration

To achieve maximum contraceptive effectiveness, oral contraceptives must be taken exactly as directed and at intervals not exceeding 24 hours.

For a DAY 1 START, count the first day of menstrual flow as Day 1 and the first tablet (white) is then taken on Day 1. For a SUNDAY START when menstrual flow begins on or before Sunday, the first tablet (white) is taken on that day. With either a DAY 1 START or SUNDAY START, 1 tablet (white) is taken each day at the same time for 21 days. Then the peach tablets are taken for 7 days, whether bleeding has stopped or not. After all 28 tablets have been taken, whether bleeding has stopped or not, the same dosage schedule is repeated beginning on the following day.

Levora () How Supplied

Levora () 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP): Each white tablet is unscored, round in shape, with debossed on one side and on the other side, and contains 0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol. Levora () 0.15/30-28 is packaged in cartons of six tablet dispensers. Each tablet dispenser contains 21 white (active) tablets and 7 peach (inert) tablets. Inert tablets are unscored, round in shape with debossed on one side and on the other side.

Store at controlled room temperature 15°-25°C (59°-77°F).

Levora () References

Array

Levora () Detailed Patient Labeling

Any woman who considers using oral contraceptives (“birth control pills” or “the pill”) should understand the benefits and risks of using this form of birth control. This leaflet will give you much of the information you will need to make this decision and also will help you determine if you are at risk of developing any of the serious side effects of the pill. It will tell you how to use the pill properly so that it will be as effective as possible. However, this leaflet is not a replacement for a careful discussion between you and your health care provider. You should discuss the information provided in this leaflet with him or her, both when you first start taking the pill and during your regular visits. You also should follow the advice of your health care provider with regard to regular checkups while you are on the pill.

Oral contraceptives are used to prevent pregnancy and are more effective than other non-surgical methods of birth control. When they are taken correctly, without missing any pills, the chance of becoming pregnant is less than 1% (1 pregnancy per 100 women per year of use). Typical failure rates are actually 3% per year. The chance of becoming pregnant increases with each missed pill during a menstrual cycle.

In comparison, typical failure rates for other nonsurgical methods of birth control during the first year are as follows:

Some women should not use the pill. For example, you should not take the pill if you are pregnant or think you may be pregnant. You also should not use the pill if you have any of the following conditions:

Tell your health care provider if you have ever had any of these conditions. Your health care provider can recommend a safer method of birth control.

Tell your health care provider if you have or have had:

Women with any of these conditions should be checked often by their health care provider if they choose to use oral contraceptives.

Also, be sure to inform your doctor or health care provider if you smoke or are on any medications.

Blood clots and blockage of blood vessels are the most serious side effects of taking oral contraceptives. In particular, a clot in the legs can cause thrombophlebitis and a clot that travels to the lungs can cause a sudden blocking of the vessel carrying blood to the lungs. Rarely, clots occur in the blood vessels of the eye and may cause blindness, double vision, or impaired vision.

If you take oral contraceptives and need elective surgery, need to stay in bed for a prolonged illness or have recently delivered a baby, you may be at risk of developing blood clots. You should consult your doctor about stopping oral contraceptives three to four weeks before surgery and not taking oral contraceptives for two weeks after surgery or during bed rest. You should also not take oral contraceptives soon after delivery of a baby. It is advisable to wait for at least four weeks after delivery if you are not breast feeding. If you are breast feeding, you should wait until you have weaned your child before using the pill ().

Oral contraceptives may increase the tendency to develop strokes (stoppage or rupture of blood vessels in the brain) and angina pectoris and heart attacks (blockage of blood vessels in the heart). Any of these conditions can cause death or temporary or permanent disability.

Smoking greatly increases the possibility of suffering heart attacks and strokes. Furthermore, smoking and the use of oral contraceptives greatly increase the chances of developing and dying of heart disease.

Oral contraceptive users may have a greater risk than non-users of having gallbladder disease, although this risk may be related to pills containing high doses of estrogen.

In rare cases, oral contraceptives can cause benign but dangerous liver tumors. These benign liver tumors can rupture and cause fatal internal bleeding. In addition, a possible but not definite association has been found with the pill and liver cancers in 2 studies in which a few women who developed these very rare cancers were found to have used oral contraceptives for long periods. However, liver cancers are extremely rare. The chance of developing liver cancer from using the pill is thus even rarer.

There is, at present, no confirmed evidence that oral contraceptives increase the risk of cancer of the reproductive organs in human studies. Several studies have found no overall increase in the risk of developing breast cancer. However, women who use oral contraceptives and have a strong family history of breast cancer or who have breast nodules or abnormal mammograms should be followed closely by their doctors. Some studies have reported an increase in the risk of developing breast cancer, particularly at a younger age. This increased risk appears to be related to duration of use.

Some studies have found an increase in the incidence of cancer of the cervix in women who use oral contraceptives. However, this finding may be related to factors other than the use of oral contraceptives.

All methods of birth control and pregnancy are associated with a risk of developing certain diseases which may lead to disability or death. An estimate of the number of deaths associated with different methods of birth control and pregnancy has been calculated and is shown in the following table:

In the above table, the risk of death from any birth control method is less than the risk of childbirth except for oral contraceptive users over the age of 35 who smoke and pill users over the age of 40 even if they do not smoke. It can be seen from the table that for women aged 15 to 39 the risk of death is highest with pregnancy (7–26 deaths per 100,000 women, depending on age). Among pill users who do not smoke the risk of death is always lower than that associated with pregnancy for any age group, although over the age of 40 the risk increases to 32 deaths per 100,000 women compared to 28 associated with pregnancy at that age. However, for pill users who smoke and are over the age of 35 the estimated number of deaths exceeds those for other methods of birth control. If a woman is over the age of 40 and smokes, her estimated risk of death is 4 times higher (117/100,000 women) than the estimated risk associated with pregnancy (28/100,000 women) in that age group.

The suggestion that women over 40 who don’t smoke should not take oral contraceptives is based on information from older high-dose pills and on less selective use of pills than is practiced today. An Advisory Committee of the FDA discussed this issue in 1989 and recommended that the benefits of oral contraceptive use by healthy, non-smoking women over 40 years of age may outweigh the possible risks. However, all women, especially older women, are cautioned to use the lowest dose pill that is effective.

If any of these adverse effects occurs while you are taking oral contraceptives, call your doctor immediately:

Irregular vaginal bleeding or spotting may occur while you are taking the pill. Irregular bleeding may vary from slight staining between menstrual periods to breakthrough bleeding which is a flow much like a regular period. Irregular bleeding occurs most often during the first few months of oral contraceptive use but may also occur after you have been taking the pill for some time. Such bleeding may be temporary and usually does not indicate any serious problem. It is important to continue taking your pills on schedule. If the bleeding occurs in more than 1 cycle or lasts for more than a few days, talk to your doctor or health care provider.

If you wear contact lenses and notice a change in vision or an inability to wear your lenses, contact your doctor or health care provider.

Oral contraceptives may cause edema (fluid retention) with swelling of the fingers or ankles and may raise your blood pressure. If you experience fluid retention, contact your doctor or health care provider.

A spotty darkening of the skin is possible, particularly of the face.

Other side effects may include change in appetite, headache, nervousness, depression, dizziness, loss of scalp hair, rash, and vaginal infections.

If any of these side effects occurs, contact your doctor or health care provider.

Featured In
footer logo
©2015,eDrugSearch,Inc. All Rights Reserved. Privacy Policy Terms of Use Contact UsSitemap
Sign In

Email Address
Password
 
Remember Me Forgot your password?
Create Account
Forgot Password

If you've forgotten your password, please enter your email address below. We'll send you an email with instructions for resetting your password.

Email Address
Create Account

Name
Email ID
Password
Human Verification
Please type the characters you see in the image.
 
I have read and agree to the terms of service
Sign In
Submit Your Blog

Sorry ! only healthcare users can submit blogs. Please Click here to login or sign up for Healthcare User.